AHA, ACC Update Guidelines for Acute Coronary Syndrome Management
Cardiovascular Magnetic Resonance Highlights Sex-Specific Characteristics in Aortic Stenosis
HeartSense's Mission to Reveal, Combat Hidden CV Burdens in Underserved Communities
Abelacimab Shows Potential to Shift the Standard of Care in AFib
Experts discuss how lipoproteins drive atherosclerotic heart disease, review the different guidelines and recommendations on Lp(a) testing, and insights from clinical trials.
CKM Treatment Involves a Team-Based Approach, Says Dr Keith Ferdinand
Tackling CKM Syndrome as a Holistic Approach to a Growing Health Crisis
Greater Awareness, Community Empowerment Needed in CVD Prevention Efforts
Ochsner Health's Connected MOM Program: Managing Hypertension During Pregnancy and Postpartum
CMS Negotiated Drug Prices: Cardiologist's View on Affordability, Future Innovation
Dr Martha Gulati Previews ESC 2024: Obesity, Heart Failure, and the Ongoing Debate on HRT
2024 ASPC Congress on CVD Prevention to Be Held in August
Dr Rashon Lane Addresses How Racial, Ethnic Inequities Factor Into Cardiometabolic Health Care
Lack of Cardiovascular Trial Diversity Is an International Issue: Dr Shrilla Banerjee Gives UK Perspective
Dr Donna Fitzsimons: “Doctor Knows Best” Mindset Wanes as Patients Become More Self-Educated
From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
Podcast: This Week in Managed Care—Setbacks for Medicaid Work Rules and Other Health News
Podcast: This Week in Managed Care—The $2 Million Gene Therapy and Other Health News
Podcast: This Week in Managed Care—CMS Drug Coverage Changes Draw Ire and Other Health News
Podcast: This Week in Managed Care—Cancer Is the New Leading Cause of Death and Other Health News
Podcast: This Week in Managed Care—Medicaid Expansion at the Ballot Box and Other Health News
Podcast: This Week in Managed Care - Dropped ACA Coverage, and Other News
Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy
FDA Expands Semaglutide Use for CV, Kidney Risks in T2D, CKD